Editorial Board

Editors-in-Chief

Seth P. Lerner

Seth P. Lerner, MD
Baylor College of Medicine
Scott Department of Urology
Houston, Texas, USA
Email: blc@iospress.com
(Epidemiology, Etiology, Molecular Genetics, Pathogenesis, Pathology, Pharmacology, Diagnosis, Treatment, Survivorship)

Dan Theodorescu

Dan Theodorescu, MD, PhD
Samuel Oschin Comprehensive Cancer Institute
Cedars-Sinai Medical Center
Los Angeles, California, USA
Email: blc@iospress.com
(Epidemiology, Etiology, Molecular Genetics, Pathogenesis, Pathology, Pharmacology, Diagnosis, Treatment, Survivorship)

Associate Editors for Reviews 

Andrea B. Apolo, MD 
National Cancer Institute, US Department of Health and Human Services, Rockville, USA
(Molecular Genetics, Pathogenesis, Pharmacology, Diagnosis, Treatment)

Georgios Gakis, MD, PhD
University Hospital Würzburg, Department of Urology, Würzburg, Germany
(Treatment)

Nathan Lawrentschuk, MD, PhD
University of Melbourne, Department of Surgery, Victoria, Australia
(Treatment)

Associate Editor of Challenging Cases in Urothelial Cancer

Mark S. Soloway, MD
Memorial Healthcare System, Aventura, USA
(Pathogenesis, Treatment)

Associate Editors of Clinical Trials Corner

Piyush K. Agarwal, MD
University of Chicago Medicine, Chicago, USA
(Pathogenesis, Pharmacology, Treatment)

Cora N. Sternberg, MD
Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, USA
(Pathogenesis, Pharmacology, Treatment)

Associate Editor of Paper Alert

Edward M. Messing, MD
University of Rochester Medical Center, Department of Urology, Rochester, USA
(Treatment)

Social Media Associate Editor

Bishoy M. Faltas, MD
Weill Cornell Medicine, New York, USA
(Etiology, Molecular Genetics, Pathogenesis, Treatment)

Assistant Social Media Editor

Kyrillus Shohdy, MD
Weill Cornell Medicine, New York, USA
(Molecular Genetics, Pathogenesis, Treatment)

Associate Editors

Rebecca Barasky, MPH 
Bladder Cancer Advocacy Network (BCAN), Bethesda, USA
(Patient-Centered Outcomes Research)

Joaquim Bellmunt, MD, PhD
Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, USA
(Treatment)

David J. DeGraff, PhD
Pennsylvania State University College of Medicine, Department of Pathology, Hershey, USA
(Molecular Genetics, Pathogenesis, Pathology)

Lars Dyrskjøt, PhD
Aarhus University, Department of Molecular Medicine, Aarhus, Denmark
(Etiology, Molecular Genetics, Pathogenesis)

Jason A. Efstathiou, MD, DPhil
Massachusetts General Hospital, Harvard Medical School, Radiation Oncology, Boston, USA
(Pathogenesis, Treatment)

Thomas Flaig, MD 
University of Colorado, Division of Medical Oncology, Aurora, USA 
(Treatment)

Donna Hansel, MD, PhD
Oregon Health & Science University, Department of Pathology & Laboratory Medicine, Portland, USA
(Pathogenesis, Pathology)

Arndt Hartmann, MD
University Erlangen-Nürnberg, Institute of Pathology, Erlangen, Germany
(Molecular Genetics, Pathogenesis, Pathology)

Anne Kiltie, MA, DM, DSc
Rowett Institute, University of Aberdeen, Aberdeen, United Kingdom
(Molecular Genetics, Pathogenesis, Treatment)

Yair Lotan, MD
UT Southwestern Medical Center, Urology Clinic, Dallas, USA 
(Pathogenesis, Treatment)

S. Bruce Malkowicz, MD
Hospital of the University of Pennsylvania, Philadelphia, USA
(Treatment)

Surena F. Matin, MD
University of Texas MD Anderson Cancer Center, Department of Urology, Division of Surgery, Houston, USA
(Molecular Genetics, Pathogenesis, Treatment)

David McConkey, PhD
Johns Hopkins Greenberg Bladder Cancer Institute and Brady Urological Institute, Johns Hopkins University, Baltimore, USA
(Molecular Genetics, Pathogenesis)

Matt Milowsky, MD 
University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, USA
(Pathogenesis, Pharmacology, Treatment)

Valeria Panebianco, MD 
University of Rome La Sapienza, Department of Radiological Sciences, Oncology and Pathology, Rome, Italy
(Pathology, Diagnosis, Treatment)

Francisco X. Real, MD, PhD
CNIO (Spanish National Cancer Research Centre), Molecular Oncology Programme, Madrid, Spain
(Molecular Genetics, Pathogenesis)

Bas W.G. van Rhijn, MD, PhD
Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
(Pathogenesis, Pathology, Diagnosis)

Gottfrid Sjödahl, Ph.D.
Lund University, Department of Translational Medicine, Lund, Sweden
(Molecular Genetics, Pathogenesis, Pathology)

Angela B. Smith, MD, MS, FACS
UNC-Chapel Hill School of Medicine, Department of Urology, Chapel Hill, USA
(Etiology, Pathogenesis, Treatment)

George Thalmann, MD 
University of Bern, Department of Urology, Bern, Switzerland
(Molecular Genetics, Pathogenesis, Treatment)

Xue-Ru Wu, MD 
New York University (NYU), Department of Urology/Pathology, New York, USA
(Molecular Genetics, Pathogenesis)

Alexandre R. Zlotta, MD, PhD
Sinai Health System, Uro-Oncology, Lunenfeld-Tanenbaum Research Institute, Toronto, Canada
Princess Margaret Cancer Centre, University Health Network, Department of Surgical Oncology, Urology, Toronto, Canada
(Treatment)

Editorial Board

Cory Abate-Shen, PhD
Columbia University Medical Center, Department of Molecular Pharmacology and Therapeutics, New York, USA
(Etiology, Molecular Genetics)

Phillip Abbosh, MD, PhD
Fox Chase Cancer Center at Temple University Hospital, Molecular Therapeutics, Philadelphia, USA
(Diagnosis, Treatment, Survivorship)

Hikmat Al-Ahmadie, MD
Memorial Sloan-Kettering Cancer Center, Department of Pathology, New York, USA
(Epidemiology, Molecular Genetics, Pathogenesis, Pathology)

Matthew L. Albert, MD, PhD
Institut Pasteur, Department of Immunology, Paris, France
(Molecular Genetics, Pathogenesis, Pharmacology, Treatment)

Jessie Au, PharmD, PhD
Optimum Therapeutics, San Diego, USA
(Pharmacology, Treatment)

Marko Babjuk, MD
Motol University Hospital and 2nd Faculty of Medicine, Department of Urology, Prague, Czech Republic
(Treatment)
 
Rick Bangs, MBA, PMP
Patient Advocate, Pittsford, USA
(Survivorship)

Trinity Bivalacqua, MD, PhD
Johns Hopkins Medicine, Department of Urology, Surgery and Oncology, Baltimore, USA
(Pathology, Diagnosis, Treatment, Survivorship)

Peter Black, MD
University of British Columbia, Department of Urology, Vancouver, Canada
(Pathology, Diagnosis, Treatment, Survivorship)

Bernard Bochner, MD 
Memorial Sloan-Kettering Cancer Center, Department of Urology, Surgery and Oncology, New York, USA
(Pathology, Diagnosis, Treatment, Survivorship)

James Catto, MD, PhD
The University of Sheffield, Academic Urology Unit, Sheffield, United Kingdom
(Molecular Genetics, Pathogenesis, Diagnosis, Treatment, Survivorship)

Karim Chamie, MD
University of California Los Angeles, Department of Urology, Los Angeles, USA
(Diagnosis, Treatment, Survivorship)

Keith Syson Chan, PhD
Samuel Oschin Comprehensive Cancer Institute, Academic Pathology, Cedars-Sinai Medical Center, Los Angeles, USA
(Etiology, Molecular Genetics, Pathogenesis, Pathology, Pharmacology)

Sam S. Chang, MD
Vanderbilt University Medical Center, Department of Urology, Nashville, USA
(Pathology, Diagnosis, Treatment, Survivorship)

Liang Cheng, MD
Indiana University, Department of Pathology & Laboratory Medicine, Indianapolis, USA
(Molecular Genetics, Pathology, Diagnosis)

Richard J. Cote, MD
Washington University, Department of Pathology and Immunology, St Louis, USA
(Etiology, Molecular Genetics, Pathogenesis, Pathology)

Bogdan Czerniak, MD, PhD
University of Texas MD Anderson Cancer Center, Department of Pathology, Houston, USA
(Epidemiology, Etiology, Molecular Genetics, Pathogenesis, Pathology)

Garrett M. Dancik, PhD
Eastern Connecticut State University, Department of Computer Science, Willimantic, USA
(Epidemiology, Etiology, Molecular Genetics)

Siamak Daneshmand, MD
University of Southern California, Department of Urology, Los Angeles, USA
(Pathology, Diagnosis, Treatment, Survivorship)

Ian D. Davis, MBBS (Hons), PhD, FRACP, FAChPM
Monash University and Eastern Health, Eastern Health Clinical School, Box Hill, Australia
(Molecular Genetics, Diagnosis, Treatment, Survivorship)

Colin P.N. Dinney, MD
University of Texas MD Anderson Cancer Center, Department of Urology, Houston, USA 
(Pathogenesis, Pathology, Pharmacology, Diagnosis, Treatment, Survivorship)

Matthew Galsky, MD
Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, USA
(Molecular Genetics, Pathogenesis, Pathology, Pharmacology, Diagnosis, Treatment, Survivorship)

Scott M. Gilbert, MD
H. Lee Moffitt Cancer Center & Research Institute, Department of Urology, Tampa, USA
(Pathology, Treatment, Survivorship)

Peter J. Goebell, MD, PhD
Universitätsklinikum Erlangen, Department of Urology, Erlangen, Germany
(Molecular Genetics, Pathogenesis, Pharmacology, Diagnosis, Treatment, Survivorship)

John Gore, MD
University of Washington, Department of Urology, Seattle, USA
(Treatment)

Noah Hahn, MD
Johns Hopkins University School of Medicine, Department of Oncology and Urology, Baltimore, USA
(Pharmacology, Diagnosis, Treatment, Survivorship)

Richard Hautmann, MD
Universität Ulm, Department of Urology, Ulm, Germany
(Diagnosis, Treatment, Survivorship)

Jean Heather Hoffman-Censits, MD
Johns Hopkins University, Baltimore, USA
(Treatment)

Jer-Tsong Hsieh, PhD
UT Southwestern Medical Center, Department of Urology, Dallas, USA
(Etiology, Molecular Genetics, Pathogenesis, Pathology)

Molly A. Ingersoll, PhD 
Institut Pasteur, Department of Immunology, Paris, France
(Pathogenesis, Pathology, Pharmacology, Treatment)

Ashish M. Kamat, MD
University of Texas MD Anderson Cancer Center, Department of Urology, Division of Surgery, Houston, USA
(Diagnosis, Treatment, Survivorship)

Lawrence Karsh, MD, FACS
The Urology Center of Colorado, Department of Clinical Research, Denver, USA
(Diagnosis, Treatment, Survivorship)

Wassim Kassouf, MD
McGill University Health Center, Department of Urology, Montreal, Canada
(Diagnosis, Treatment, Survivorship)

Lambertus (Bart) Kiemeney, PhD 
Radboud University Medical Center, Department of Health Evidence, Nijmegen, The Netherlands
(Epidemiology, Etiology, Molecular Genetics, Pathology, Pharmacology)

William Kim, MD
University of North Carolina, Department of Medicine, Chapel Hill, USA
(Molecular Genetics, Pathogenesis, Pathology, Pharmacology, Diagnosis, Treatment, Survivorship)

Deborah W. Knapp, DVM
Purdue University, Department of Veterinary Clinical Sciences, West Lafayette, USA
(Epidemiology, Etiology, Molecular Genetics, Pathogenesis, Pathology, Pharmacology)

Margaret Knowles, PhD
Leeds Institute of Cancer & Pathology, Department of Experimental Oncology, Leeds, United Kingdom
(Epidemiology, Etiology, Molecular Genetics, Pathogenesis, Pathology)

Badrinath Konety, MD
University of Minnesota, Department of Urology, Minneapolis, USA
(Diagnosis, Treatment, Survivorship)

David J. Kwiatkowski, MD, PhD
Brigham and Women's Hospital, Harvard Medical School, Department of Medicine, Boston, USA
(Etiology, Molecular Genetics, Pathogenesis, Diagnosis)

Donald Lamm, MD
University of Arizona, Department of Surgery, Phoenix, USA
(Diagnosis, Treatment, Survivorship)

David Latini, PhD
Baylor College of Medicine, Department of Urology, Houston, USA
(Survivorship)

Nathan Lawrentschuk, MD, PhD
University of Melbourne, Department of Surgery, Victoria, Australia
(Pharmacology, Diagnosis, Treatment, Survivorship)

Cheryl Lee, MD
The Ohio State University Wexner Medical Center, Columbus, USA
(Diagnosis, Treatment, Survivorship)

Vinata Lokeshwar, PhD
Augusta University Medical College of Georgia, Department of Biochemistry and Molecular Biology, Augusta, USA
(Epidemiology, Etiology, Molecular Genetics, Pathogenesis, Pathology, Pharmacology)

Nuria Malats, MD
CNIO (Spanish National Cancer Research Centre), Genetic and Molecular Epidemiology Group, Madrid, Spain
(Epidemiology, Etiology, Molecular Genetics, Pathogenesis, Pathology)

Kazumasa Matsumoto, MD
Kitasato University, Department of Urology, Kanagawa, Japan 
(Treatment)

James McKiernan, MD
Columbia University, Department of Urology, New York, USA
(Pharmacology, Diagnosis, Treatment, Survivorship)

Reza Mehrazin, MD
The Mount Sinai Hospital, Department of Urology, New York, USA
(Treatment)

Maxwell Meng, MD
University of California San Francisco, Department of Urology, San Francisco, USA
(Pathogenesis, Treatment)

Timur Mitin, MD, PhD
Oregon Health and Science University, Portland, USA
(Treatment)

Anirban P. Mitra, MD, PhD
University of Southern California, Institute of Urology, Los Angeles, USA
(Etiology, Molecular Genetics, Pathogenesis, Pathology, Pharmacology, Diagnosis, Treatment, Survivorship)

Ofer Nativ, MD
Bnai Zion Medical Center, Department of Urology, Haifa, Israel
(Treatment)

Roman Nawroth, PhD
Klinikum rechts der Isar, Technical University of Munich, Department of Urology, Munich, Germany
(Molecular Genetics, Pathogenesis, Pharmacology, Treatment)

Matthew Nielsen, MD
UNC School of Medicine, Department of Urology, Chapel Hill, USA
(Treatment)

Hiroyuki Nishiyama, MD, PhD
University of Tsukuba, Department of Urology, Tsukuba, Japan
(Treatment)

Michael A. O'Donnell, MD
University of Iowa Carver College of Medicine, Department of Urology, Iowa City, USA
(Etiology, Pathogenesis, Pathology, Pharmacology, Diagnosis, Treatment, Survivorship)

Torben Ørntoft, MD 
Aarhus University Hospital, Department of Clinical Medicine, Aarhus, Denmark
(Epidemiology, Etiology, Molecular Genetics)

Joan Palou Redorta, MD, PhD
Universitat Autònoma de Barcelona, Fundació Puigvert, Department of Urology, Barcelona, Spain
(Treatment)

Howard L. Parnes, MD
National Cancer Institute, NIH, Devision of Cancer Prevention, Bethesda, USA
(Etiology, Treatment)

Dan Petrylak, MD
Yale University, Department of Medical Oncology, New Haven, USA
(Diagnosis, Treatment, Survivorship)

Elizabeth R. Plimack, MD
Fox Chase Cancer Center, Department of Hematology/Oncology, Philadelphia, USA
(Pharmacology, Diagnosis, Treatment, Survivorship)

Kamal Pohar, MD
Ohio State University, Department of Urology, Columbus, USA
(Treatment)

Michael P. Porter, MD
University of Washington, Department of Urology, Seattle, USA
(Epidemiology, Treatment)

Ludmila Prokunina-Olsson, PhD
National Cancer Institute, Laboratory of Translational Genomics,Division of Cancer Epidemiology and Genetics, Bethesda, USA
(Etiology, Molecular Genetics, Pathogenesis)

Sarah P. Psutka, MD, MS
University of Washington, Department of Urology, Seattle, USA
(Etiology, Treatment)

Nagireddy Putluri, PhD
Baylor College of Medicine, Dept. of Molecular and Cellular Biology, Houston, USA
(Molecular Genetics, Pathogenesis, Diagnosis)

David Quinn, MBBS, PhD
University of Southern California, Norris Comprehensive Cancer Center, Department of Medicine, Los Angeles, USA
(Pharmacology, Diagnosis, Treatment, Survivorship)

François Radvanyi, PhD
Institut Curie - UMR 144 - CNRS, Department of Cell Biology and Cancer, Paris, France
(Etiology, Molecular Genetics, Pathology)

Derek Raghavan, MD, PhD
Levine Cancer Institute, Atrium Health, Charlotte, USA
(Diagnosis, Treatment, Survivorship)

Leonardo O Reis, MD, MSc, PhD
University of Campinas, Sao Paulo, Brazil
(Treatment)

Cyrill Rentsch, MD, PhD
University Hospital Basel, Division of Urology, Basel, Switzerland 
(Pathology, Diagnosis, Treatment)

Jonathan Rosenberg, MD
Memorial Sloan-Kettering Cancer Center, Department of Medical Oncology, New York, USA
(Pharmacology, Diagnosis, Treatment, Survivorship)

Arthur I. Sagalowsky, MD
UT Southwestern Medical Center, Department of Urology, Dallas, USA
(Diagnosis, Treatment, Survivorship)

Maria De Santis, MD
Charité University Hospital, Interdisciplinary GU Oncology, Department of Urology, Berlin, Germany
(Treatment)

Marta Sánchez-Carbayo, PhD
University of the Basque Country, Department of Cancer Research, Bilbao, Spain
(Epidemiology, Etiology, Molecular Genetics, Pathogenesis, Pathology)

Bernd J. Schmitz-Dräger, MD, PhD
Friedrich-Alexander University, Department of Urology and Pediatric Urology, Erlangen, Germany
(Epidemiology, Etiology, Molecular Genetics, Pathogenesis, Pathology)

Mark P. Schoenberg, MD
The Albert Einstein College of Medicine & The Montefiore Medical Center, Department of Urology, New York, USA
(Pharmacology, Diagnosis, Treatment, Survivorship)

John P. Sfakianos, MD
Assistant Professor, Urologic Oncology, Department of Urology, Icahn School of Medicine at Mount Sinai, New York, USA
(Pathogenesis, Treatment)

Shahrokh F. Shariat, MD, PhD
Medical University Vienna, Department of Urology, Vienna, Austria
(Pharmacology, Diagnosis, Treatment, Survivorship)

Padmanee Sharma, MD, PhD
University of Texas MD Anderson Cancer Center, Department of Genitourinary Medical Oncology and Immunology, Houston, USA
(Molecular Genetics, Pathogenesis, pathology, Diagnosis, Treatment)

Eila C. Skinner, MD 
Stanford University, Department of Urology, Stanford, USA
(Diagnosis, Treatment, Survivorship)

Carolyn L. Smith, PhD
Baylor College of Medicine, Molecular & Cellular Biology, Houston, USA
(Diagnosis, Treatment, Survivorship)

Norm Smith, MD
Northshore University HealthSystem, Chicago, USA
(Treatment)

Steven Christopher Smith, MD, PhD
Virginia Commonwealth University, School of Medicine, Richmond, USA
(Molecular Genetics, Pathogenesis, pathology, Diagnosis, Treatment)

Walter Stadler, MD, FACP
University of Chicago, Comprehensive Cancer Center, Chicago, USA
(Pharmacology, Diagnosis, Treatment, Survivorship)

Gary Steinberg, MD
NYU Langone Health, Department of Urology, New York, USA
(Pharmacology, Diagnosis, Treatment, Survivorship)

Arnulf Stenzl, MD
Universitätsklinikum Tübingen, Department of Urology, Tübingen, Germany
(Pharmacology, Diagnosis, Treatment, Survivorship)

Seth Strope, MD
Baptist MD Anderson Cancer Center, Jacksonville, Florida, USA
(Treatment)

Hyun Hwan Sung, MD, PhD
Samsung Medical Center, Department of Urology, Seoul, Korea
(Treatment)

Robert Svatek, MD, MSCI
UT Health Science Center San Antonio, Department of Urology, San Antonio, USA
(Diagnosis, Treatment, Survivorship)

John A. Taylor, III, MD, MS
University of Kansas Medical Center, Department of Urology, Kansas City, USA
(Pharmacology, Diagnosis, Treatment, Survivorship)

Jennifer M. Taylor, MD, MPH
Baylor College of Medicine/DeBakey VAMC Houston, USA
(Diagnosis, Treatment, Survivorship)

Antonia Vlahou, PhD
Biomedical Research Foundation Academy of Athens, Department of Systems Biology, Athens, Greece
(Epidemiology, Etiology, Molecular Genetics, Pathogenesis, Pathology)

Nicholas Vogelzang, MD, FASCO 
Comprehensive Cancer Centers of Nevada, Department of Medical Oncology, Las Vegas, USA
(Pharmacology, Diagnosis, Treatment, Survivorship)

J. Alfred Witjes, MD, PhD
Radboud University Nijmegen, Department of Urology, Nijmegen, The Netherlands
(Etiology, Molecular Genetics, Pathogenesis, Pathology, Pharmacology)

Diane Zipursky Quale, BA, JD
Bladder Cancer Advocacy Network (BCAN), Bethesda, USA
(Survivorship)

Statistical and Bioinformatics Editorial Board

Debashis Ghosh, PhD
University of Colorado, Department of Biostatistics and Informatics, Aurora, USA
(Etiology, Molecular Genetics)

Susan Groshen, PhD
University of Southern California, Department of Preventive Medicine, Los Angeles, USA
(Epidemiology, Etiology, Molecular Genetics)

Michael C. Sachs, PhD
Karolinska Institute, Department of Medical Epidemiology and Biostatistics, Stockholm, Sweden
(Epidemiology)

Richard Sylvester, ScD
EORTC, Brussels, Belgium
(Epidemiology, Etiology, Molecular Genetics)

Jeremy Taylor, PhD
University of Michigan, Department of Biostatistics, Ann Arbor, USA
(Epidemiology)